Overview
Morningstar has been rating stocks and funds since 1984, and Morningstar Investor is the modern, consumer-facing subscription version of that research: the familiar 1-to-5 Star Rating (price versus a calculated Fair Value estimate), an Economic Moat rating (wide, narrow, or none, based on competitive advantages like network effects or switching costs), and a Fair Value Estimate on every covered name. Around 120 in-house analysts write full reports on roughly 1,000 of the largest, most-followed US stocks; a quantitative model trained on those analysts' own ratings extends coverage to another 12,000-plus US and international companies that don't get a human write-up.
Important to understand going in: Morningstar Investor rates and estimates value, it doesn't publish a curated "buy this now" list the way a stock-picking newsletter does. It's a research and screening tool you use to evaluate ideas, not a service that hands you a short list and a reason to act on it today.
What you get
- Star Rating, Economic Moat, and Fair Value Estimate on roughly 1,000 analyst-covered stocks, plus quant-model ratings extending to 12,000-plus more
- Full-length analyst reports on covered names, often several thousand words, covering the business model, competitive position, and risks
- A 200-plus-data-point screener across stocks, mutual funds, and ETFs
- Portfolio analysis tools (an X-Ray-style breakdown of holdings, overlap, and risk)
- Model portfolios and curated "best stocks" style newsletters (like StockInvestor) are separate, additionally-paid Morningstar products, not included in base Investor
On the analyst-plus-quant coverage model
Morningstar doesn't claim a single win-rate or headline return figure for Investor the way a stock-picking newsletter does, and we didn't find one in its marketing, which is itself worth noting positively. But the coverage model is worth understanding: only about 1,000 of the largest, most-followed stocks get a full human analyst report and moat rating. Everything else, more than 12,000 additional companies, gets an algorithmic rating from a model trained on those same analysts' historical calls, not a written opinion from a person. That's a reasonable way to scale coverage, but it means the depth you're paying for is concentrated in large, well-known names, and thinner elsewhere. Separately, Morningstar Credit Ratings, a distinct structured-finance subsidiary that has nothing to do with this consumer product, paid the SEC $3.5 million in 2020 and $1.15 million in a related case over conflict-of-interest and internal-controls failures in its bond-rating business. Worth disclosing as firm-level context, not as a knock on the Investor product itself.
Pricing
Morningstar Investor runs $34.95/month or $249/yr at list price, with a commonly available $199 first-year intro rate through promotional links (not combinable with other offers, and not usable to extend an existing subscription). A 7-day free trial is available before the first charge. We couldn't confirm Morningstar's exact refund terms from a primary source; independent complaint records describe subscriptions as largely non-refundable once the trial period ends, with at least one case where a customer was given only a prorated, not full, refund after cancelling.
Pros and cons
What stands out
- Genuinely broad coverage: over 12,000 stocks and funds rated, not a handful of curated picks
- Doesn't lead with a self-published win-rate or return claim the way most stock-picking newsletters do
- Long-form analyst reports go deeper into moat and valuation reasoning than most competitors in this category
- Screener and portfolio tools add ongoing utility beyond just reading picks
Where it falls short
- Rates and estimates value, doesn't hand you a curated buy list, a different job than most services in this category
- Only around 1,000 stocks get a full human analyst report; the rest rely on a quant model
- Reports assume real balance-sheet literacy, a steeper learning curve for beginners
- Refund terms are unclear and BBB records describe at least one prorated-only refund case
Verdict
Morningstar Investor is one of the more substantive, credible research subscriptions in this category precisely because it doesn't try to be a stock-picking newsletter, it rates thousands of stocks and funds on a consistent, disclosed framework and lets you decide what to do with that. That makes it a strong fit if you want a research tool to evaluate ideas yourself, and a weaker fit if you specifically want a short list of "buy this now" recommendations with a built-in rationale, which is what several of its lower-cost competitors in this category actually deliver.
Frequently asked questions
Is Morningstar Investor worth it?
If you want deep, broad research and valuation tools to evaluate stocks and funds yourself, yes, it's one of the most substantive options in this category. If you want a curated list of picks with a "buy now" call attached, it's a weaker fit than a dedicated stock-picking newsletter.
Does Morningstar Investor give buy recommendations?
Not in the way a newsletter does. It rates stocks (Star Rating, Moat, Fair Value) rather than publishing a curated "buy this now" list; model portfolios and picks-style newsletters are separate, additionally-paid Morningstar products.
Is Morningstar's star rating system reliable?
It's one of the most established rating frameworks in the industry, though a 2017 Wall Street Journal analysis questioned its predictive power, which Morningstar publicly rebutted with its own data. Treat it as one input, not a guarantee.
Curious about Morningstar Investor?
7-day free trial, then $199 the first year (commonly offered), renewing at $249/yr ($34.95/mo).
Visit Morningstar Investor →